Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Citation
Simpson , C R , Kerr , S , Katikireddi , S V , McCowan , C , Ritchie , L D , Pan , J , Stock , S J , Rudan , I , Tsang , R S M , de Lusignan , S , Hobbs , F D R , Akbari , A , Lyons , R A , Robertson , C & Sheikh , A 2022 , ' Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland ' , Nature Communications , vol. 13 , 4800 . https://doi.org/10.1038/s41467-022-32264-6